Inogen | INGN - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
Abbott USD 3.27B 138M 2026-03
Accuray USD 124.78M 2.54M 2025-12
AngioDynamics USD 36.57M 3.79M 2025-09
Artivion USD 55.75M 4.54M 2025-12
AtriCure USD 84.55M 6.21M 2026-03
Baxter International USD 728M 33M 2026-03
Becton, Dickinson and Co. USD 1.21B 180M 2026-03
Boston Scientific USD 1.78B 53M 2026-03
Chart Industries USD 152M 32.7M 2026-03
Cooper Companies USD 676.2M 303.1M 2026-03
Dexcom USD 349.7M 49.8M 2026-03
Edwards Lifesciences USD 522.2M 80.7M 2026-03
Globus Medical USD 297.77M 20.7M 2026-03
Inogen USD 43.77M 510K 2024-06
Insulet USD 317.2M 14.2M 2026-03
Medtronic 2.96B 9M 2025-12
Orthofix International USD 130.35M 11.31M 2025-12
Philips EUR 1.18B 121M 2026-03
ResMed USD 279.8M 1.4M 2026-03
Steris USD 351.8M 500K 2026-03
Stryker USD 2.15B 17M 2026-03
Tandem Diabetes Care USD 99.86M 5.34M 2025-12
Teleflex USD 226.01M 3.64M 2026-03
X T L Biopharmaceuticals USD 706K 50K 2024-12
Zimmer Biomet Holdings USD 849.9M 5.8M 2026-03